Thermo Fisher Scientific (TMO) Revenue — Quarter Ended Mar 30, 2024
Revenue declined in the current quarter compared with the immediately preceding quarter. It also fell relative to the same quarter one year earlier.
Key takeaway
Quarter ended Mar 30, 2024 · FY2024 Q1
Revenue declined in the current quarter compared with the immediately preceding quarter. It also fell relative to the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$10.3B
Revenue reported for this quarter.
Quarter-over-quarter
-5.0%
Change from the immediately preceding quarter.
Year-over-year
-3.4%
Change from the comparable year-ago quarter.
Trailing four quarters
$42.5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jul 1, 2023 | $10.7B | -2.6% |
| Sep 30, 2023 | $10.6B | -1.0% |
| Dec 31, 2023 | $10.9B | -4.9% |
| Mar 30, 2024 | $10.3B | -3.4% |
Revenue performance
The reported revenue moved downward, continuing a pattern of sequential decreases seen in recent quarters.
Quarterly comparison
Compared with the prior quarter, revenue was lower. Versus the same quarter a year ago, revenue also decreased.
What to watch
The persistent sequential revenue declines may warrant attention to underlying demand trends.